The Culture Of Health In Early Care And Education: Workers’ Wages, Health, And Job Characteristics

por Otten, Jennifer J., Bradford, Victoria A., Stover, Bert, Hill, Heather D., Osborne, Cynthia, Getts, Katherine, Seixas, Noah
Publicado 2019

Sotatercept (ACE-011) for the treatment of chemotherapy-induced anemia in patients with metastatic breast cancer or advanced or metastatic solid tumors treated with platinum-based...

por Raftopoulos, Haralambos, Laadem, Abderrahmane, Hesketh, Paul J., Goldschmidt, Jerome, Gabrail, Nashat, Osborne, Cynthia, Ali, Muhammad, Sherman, Matthew L., Wang, Ding, Glaspy, John A., Puccio-Pick, Marie, Zou, Jun, Crawford, Jeffrey
Publicado 2015

Phase I Study of Elacestrant (RAD1901), a Novel Selective Estrogen Receptor Degrader, in ER-Positive, HER2-Negative Advanced Breast Cancer

por Bardia, Aditya, Kaklamani, Virginia, Wilks, Sharon, Weise, Amy, Richards, Donald, Harb, Wael, Osborne, Cynthia, Wesolowski, Robert, Karuturi, Meghan, Conkling, Paul, Bagley, Rebecca G., Wang, Yamei, Conlan, Maureen G., Kabos, Peter
Publicado 2021

Randomized phase-II evaluation of letrozole plus dasatinib in hormone receptor positive metastatic breast cancer patients

por Paul, Devchand, Vukelja, Svetislava J., Ann Holmes, Frankie, Blum, Joanne L., McIntyre, Kristi J., Lindquist, Deborah L., Osborne, Cynthia R., Sanchez, Ines J., Goldschmidt, Jerome H., Wang, Yunfei, Asmar, Lina, Strauss, Lewis, O’Shaughnessy, Joyce
Publicado 2019

Pathologic complete response after preoperative anti-HER2 therapy correlates with alterations in PTEN, FOXO, phosphorylated Stat5, and autophagy protein signaling

por Holmes, Frankie Ann, Espina, Virginia, Liotta, Lance A, Nagarwala, Yasir M, Danso, Michael, McIntyre, Kristi J, Osborne, Cynthia R C, Anderson, Thomas, Krekow, Lea, Blum, Joanne L, Pippen, John, Florance, Allison, Mahoney, Janine, O’Shaughnessy, Joyce A
Publicado 2013

Five‐year results of a phase II trial of preoperative 5‐fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2‐positive...

por Holmes, Frankie Ann, Hellerstedt, Beth A., Pippen, John E., Vukelja, Svetislava J., Collea, Rufus P., Kocs, Darren M., Blum, Joanne L., McIntyre, Kristi J., Barve, Minal A., Brooks, Barry D., Osborne, Cynthia R., Wang, Yunfei, Asmar, Lina, O'Shaughnessy, Joyce
Publicado 2018

Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer Patients with Brain Metastases: A DESTINY-Breast01 Subgroup Analysis

por Jerusalem, Guy, Park, Yeon Hee, Yamashita, Toshinari, Hurvitz, Sara A., Modi, Shanu, Andre, Fabrice, Krop, Ian E., Gonzàlez Farré, Xavier, You, Benoit, Saura, Cristina, Kim, Sung-Bae, Osborne, Cynthia R., Murthy, Rashmi K., Gianni, Lorenzo, Takano, Toshimi, Liu, Yali, Cathcart, Jillian, Lee, Caleb, Perrin, Christophe
Publicado 2022